Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Financials | 11.15% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 8.02% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FPI
4151
Farmland Partners
FPI
$415M
| $4.73M | ﹤0.01% |
488,155
+30,124
| +7% | +$302K |
|
4152
ZipRecruiter
ZIP
$339M
| $4.72M | ﹤0.01% |
1,211,254
+66,096
| +6% | +$297K |
|
|
IPX
4153
IperionX
IPX
$733M
| $4.72M | ﹤0.01% |
130,506
+75,034
| +135% | +$3.07M |
|
4154
Xtrackers Low Beta High Yield Bond ETF
HYDW
$65.1M
| $4.72M | ﹤0.01% |
100,001
| – | – |
|
4155
Rayonier Advanced Materials
RYAM
$562M
| $4.71M | ﹤0.01% |
799,108
+268,473
| +51% | +$1.74M |
|
4156
First Trust United Kingdom AlphaDEX Fund
FKU
$38.2M
| $4.69M | ﹤0.01% |
92,195
-7,304
| -7% | -$354K |
|
4157
Keros Therapeutics
KROS
$197M
| $4.69M | ﹤0.01% |
230,492
-164,611
| -42% | -$2.89M |
|
4158
Gladstone Investment Corp
GAIN
$642M
| $4.69M | ﹤0.01% |
335,654
+17,718
| +6% | +$245K |
|
4159
ThredUp
TDUP
$765M
| $4.69M | ﹤0.01% |
733,808
-727,237
| -50% | -$5.88M |
|
|
NAVN
4160
Navan Inc
NAVN
$6.76B
| $4.69M | ﹤0.01% |
+274,399
| New | +$4.36M |
|
4161
Dimensional World ex US Core Equity 2 ETF
DFAX
$11.6B
| $4.68M | ﹤0.01% |
143,107
+13,333
| +10% | +$425K |
|
4162
Cornerstone Strategic Value Fund
CLM
$2.16B
| $4.67M | ﹤0.01% |
558,877
+57,973
| +12% | +$479K |
|
|
PFL
4163
PIMCO Income Strategy Fund
PFL
$382M
| $4.67M | ﹤0.01% |
553,865
+37,159
| +7% | +$313K |
|
|
ZBIO
4164
Zenas BioPharma
ZBIO
$1.96B
| $4.66M | ﹤0.01% |
128,335
+39,602
| +45% | +$1.3M |
|
|
CBL
4165
CBL Properties
CBL
$1.84B
| $4.65M | ﹤0.01% |
125,659
-208
| -0.2% | -$6.79K |
|
|
BA.PRA
4166
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
$7.76B
| $4.65M | ﹤0.01% |
67,300
-32,224
| -32% | -$2.15M |
|
4167
Preformed Line Products
PLPC
$1.39B
| $4.64M | ﹤0.01% |
22,470
-12,981
| -37% | -$2.77M |
|
4168
iShares International Treasury Bond ETF
IGOV
$1.51B
| $4.64M | ﹤0.01% |
111,409
-162,383
| -59% | -$6.85M |
|
4169
Under Armour Class C
UA
$2.95B
| $4.61M | ﹤0.01% |
960,167
+422,334
| +79% | +$1.88M |
|
|
PGZ
4170
Principal Real Estate Income Fund
PGZ
$68.1M
| $4.61M | ﹤0.01% |
460,262
+42,378
| +10% | +$433K |
|
|
AMRN
4171
Amarin Corp
AMRN
$297M
| $4.61M | ﹤0.01% |
330,109
+60,446
| +22% | +$997K |
|
4172
TMC The Metals Company
TMC
$1.49B
| $4.61M | ﹤0.01% |
746,582
-939,613
| -56% | -$6.6M |
|
|
CBLL
4173
CeriBell Inc
CBLL
$673M
| $4.6M | ﹤0.01% |
209,668
+55,123
| +36% | +$855K |
|
4174
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund
TLTD
$656M
| $4.59M | ﹤0.01% |
49,528
+281
| +0.6% | +$25.3K |
|
|
EDF
4175
Virtus Stone Harbor Emerging Markets Income Fund
EDF
$165M
| $4.58M | ﹤0.01% |
921,403
+77,402
| +9% | +$381K |
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 427 new, 3,948 increased, 2,961 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.